New Joint Survey from Compass Pathways and the Depression and Bipolar Support Alliance Reveals the Lived Burden of Treatment-Resistant Depression on Patients and Caregivers

Suzanne Baber, Chief Executive Officer, Depression and Bipolar Support Alliance

“These results give voice to the realities faced by people living with TRD and the caregivers who support them – experiences that too often go unseen or misunderstood”

Suzanne Baber, Chief Executive Officer, Depression and Bipolar Support Alliance

“Further, they reinforce the urgent need to improve access to support and to encourage clinicians to evaluate other treatment options earlier in their patients’ care.”

Suzanne Baber, Chief Executive Officer, Depression and Bipolar Support Alliance

“By bringing these lived experiences into the open, we can build a greater understanding of TRD and advocate for meaningful change that helps people feel seen, heard and supported by the broader healthcare community.”

Steve Levine, MD, Chief Patient Officer, Compass Pathways

“These findings underscore the immense toll treatment-resistant depression can take on nearly every aspect of a person’s life, from their sense of hope and identity to their relationships, careers and ability to participate in the moments that matter”

Steve Levine, MD, Chief Patient Officer, Compass Pathways

“They also make clear that the impact extends far beyond the individual, with caregivers and families carrying a significant emotional, physical and financial burden of their own.”

Steve Levine, MD, Chief Patient Officer, Compass Pathways

“These voices reinforce our commitment to listening to and learning from the TRD community as we work to deliver a new treatment option with the potential to help people move beyond simply getting through each day and toward being present in their own lives.”